Side-by-side comparison of AI visibility scores, market position, and capabilities
India YC W20 exam prep platform at $6.9M revenue 2024 (up from $3.6M) with 14M+ students at 10 users/minute; $261K funded with 100K+ videos competing with Unacademy for K-12/UPSC/IIT-JEE digital learning.
EduRev is a Gurugram, India-based edtech platform — backed by Y Combinator (W20) with $261,000 in funding from Y Combinator, Jaarvis Accelerator, Neebhaw Ventures, and angel investor Anand Chandrasekaran — providing 14+ million Indian students with a comprehensive exam preparation platform for K-12, UPSC, CAT, NEET, IIT-JEE, GATE, and other competitive examinations through 100,000+ videos, 250,000+ notes, and a social networking layer that connects students and teachers in subject-specific communities. Growing at 10 new users per minute, EduRev generated $6.9 million in revenue in 2024 (up from $3.6 million), earning recognition as Best App from Google, the mBillionth award from the Bill and Melinda Gates Foundation, and Startup of the Year from TiEcon.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.